AlphaFold predicted structure
GTPBP1 · O00178

Mean pLDDT
77.7/ 100
Confident
669 residues
Confidence breakdown
- Very high(≥ 90)53%
- Confident(70–90)23%
- Low(50–70)3%
- Very low(< 50)22%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
GTP binding protein 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalneurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1
neurodegenerative disease
prostate carcinoma
Emery-Dreifuss muscular dystrophy
disorder of ear
cholelithiasis
diverticular disease
chronic kidney disease
nonpapillary renal cell carcinoma
infection
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
GTP-binding protein 1
GTPase that plays a role in the elongation phase of protein synthesis by forming ternary complexes with GTP and aminoacyl-transfer RNAs (aa-tRNAs), and delivering aa-tRNAs to the ribosomal A site in a GTP-dependent manner (PubMed:30108131). Is also able to deliver deacylated tRNA to the A site (PubMed:30108131). Additionally, it is involved in RNA quality control; after GTP hydrolysis, which is not immediately followed by rapid peptide bond formation, GTPBP1 likely retains aa-tRNA in the A site and promotes exosomal degradation of faulty mRNAs engaged in 80S elongation complexes (PubMed:30108131). Plays a role in the regulation of circadian mRNA stability (By similarity)
GTPBP1 · O00178

Mean pLDDT
77.7/ 100
Confident
669 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0